Nanalysis Scientific (NSCI.V) after trade Wednesday reported a narrower loss and higher revenue for the first quarter.
The manufacturer of portable Nuclear Magnetic Resonance (NMR) spectrometers lost $1.28 million in the quarter, compared with a loss of $1.31 million a year earlier. The company said the decline in net loss was due to improved business margins in 2026.
Total sales and revenue rose slightly to $10.7 million from $10.6 million in the year-ago quarter. "While there was a decline in product revenue due to lower NMR benchtop sales and the termination of the third-party equipment sales contracts, security services revenue increased primarily due to higher levels of project-related work associated with the Airport Security Maintenance Business," the company said.
Adjusted EBITDA increased 62% to $292,000 from $180,000 in the first quarter of 2025. The company said this was mainly due to an increase in services margin and lower spending in sales and marketing expenses and general and administrative expenses, offset by lower product sales.
"Our outlook has not changed, and we continue to expect improved operational performance through 2026," Chief Executive Sean Krakiwsky said, adding that "while macroeconomic conditions continue to impact purchasing timelines in the Scientific Equipment segment, we remain focused on disciplined execution and long-term value creation across both operating segments."
The company's shares closed unchanged at C$0.15 on the TSX Venture Exchange.